80 related articles for article (PubMed ID: 34188271)
1. Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.
De A; Godse K; Dhoot D; Sarda A
Indian J Dermatol; 2021; 66(2):159-164. PubMed ID: 34188271
[TBL] [Abstract][Full Text] [Related]
2. Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study.
De A; Singh S; Chakraborty D; Sarda A; Godse K
Indian J Dermatol; 2024; 69(2):132-136. PubMed ID: 38841225
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.
Sinha VV; Kalikar MV; Mukhi JI; Giradkar AB; Sontakke S
Perspect Clin Res; 2023; 14(4):180-186. PubMed ID: 38025284
[TBL] [Abstract][Full Text] [Related]
4. Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks.
Jain V; Giménez-Arnau A; Hayama K; Reich A; Carr W; Tillinghast J; Dahale S; Lheritier K; Walsh P; Zharkov A; Hugot S; Haemmerle S
J Allergy Clin Immunol; 2024 Feb; 153(2):479-486.e4. PubMed ID: 37866460
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
Weller K; Gimenez-Arnau AM; Baron J; Brehler R; Ferrer M; Groffik A; Grundmann S; Jakob T; Labrador-Horrillo M; Müller S; Staubach P; Wurpts G; Metz M; Maurer M
Allergy; 2024 Jan; 79(1):93-103. PubMed ID: 37597162
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of Zhiyang Xiaozhen granules combined with second-generation antihistamine in the treatment of chronic urticaria.
Zhang L; Yang B; Cao Q; Peng C; Chen M; Su J; Chen X; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):175-181. PubMed ID: 38755713
[TBL] [Abstract][Full Text] [Related]
7. Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial.
Altrichter S; Giménez-Arnau AM; Bernstein JA; Metz M; Bahadori L; Bergquist M; Brooks L; Ho CN; Jain P; Lukka PB; Rodriguez-Suárez E; Walton C; Datto CJ;
Br J Dermatol; 2024 Feb; ():. PubMed ID: 38367194
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study.
Hollis K; Proctor C; McBride D; Balp MM; McLeod L; Hunter S; Tian H; Khalil S; Maurer M
Am J Clin Dermatol; 2018 Apr; 19(2):267-274. PubMed ID: 29368043
[TBL] [Abstract][Full Text] [Related]
9. Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.
Leceta A; Sologuren A; Valiente R; Campo C; Labeaga L
Drugs Context; 2017; 6():212500. PubMed ID: 28210286
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador.
Cherrez A; Maurer M; Weller K; Calderon JC; Simancas-Racines D; Cherrez Ojeda I
World Allergy Organ J; 2017; 10(1):21. PubMed ID: 28546850
[TBL] [Abstract][Full Text] [Related]
11. The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.
Augustin M; Beier D; Branner J; Häckl D; Hampel R; Kramps T; Kurzen H; Lintener H; Melzer N; Müller M; Staubach P; Schwichtenberg U; Termeer C; Zink A; Nathan P; Maurer M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38733261
[TBL] [Abstract][Full Text] [Related]
12. Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study.
Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos N; Rodriguez Del Rio P;
Drugs Context; 2024; 13():. PubMed ID: 38742145
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Safety of Bilastine 10 mg/d in Children Aged 2 to 5 Years With Allergic Rhinoconjunctivitis or Urticaria: A Phase 3 Clinical Trial.
Majorek-Olechowska B; Slomskis T; Zollerová L; Martín I; Sánchez C; Gilaberte I; Arranz P;
J Investig Allergol Clin Immunol; 2024 May; ():0. PubMed ID: 38725318
[TBL] [Abstract][Full Text] [Related]
14. Disease burden and predictors associated with non-response to antihistamine-based therapy in chronic spontaneous urticaria.
Soong W; Patil D; Pivneva I; Signorovitch J; Wells MA; Balp MM; Kuruvilla M
World Allergy Organ J; 2023 Dec; 16(12):100843. PubMed ID: 38075554
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of patients with chronic spontaneous urticaria in treatment with vitamin D supplement.
Ariaee N; Zarei S; Mohamadi M; Jabbari F
Clin Mol Allergy; 2017; 15():22. PubMed ID: 29299028
[TBL] [Abstract][Full Text] [Related]
16. Insights on molecular modeling and supramolecular arrangement of bilastine polymorphs.
Santin LG; Moreira LF; Oliveira NVC; Paiva VLA; Ribeiro MR; Oliveira SS; Napolitano HB
J Mol Model; 2024 May; 30(5):157. PubMed ID: 38698260
[TBL] [Abstract][Full Text] [Related]
17. Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.
Leceta A; García A; Sologuren A; Campo C
Drugs Context; 2021; 10():. PubMed ID: 34457015
[TBL] [Abstract][Full Text] [Related]
18. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
Zuberbier T; Abdul Latiff AH; Abuzakouk M; Aquilina S; Asero R; Baker D; Ballmer-Weber B; Bangert C; Ben-Shoshan M; Bernstein JA; Bindslev-Jensen C; Brockow K; Brzoza Z; Chong Neto HJ; Church MK; Criado PR; Danilycheva IV; Dressler C; Ensina LF; Fonacier L; Gaskins M; Gáspár K; Gelincik A; Giménez-Arnau A; Godse K; Gonçalo M; Grattan C; Grosber M; Hamelmann E; Hébert J; Hide M; Kaplan A; Kapp A; Kessel A; Kocatürk E; Kulthanan K; Larenas-Linnemann D; Lauerma A; Leslie TA; Magerl M; Makris M; Meshkova RY; Metz M; Micallef D; Mortz CG; Nast A; Oude-Elberink H; Pawankar R; Pigatto PD; Ratti Sisa H; Rojo Gutiérrez MI; Saini SS; Schmid-Grendelmeier P; Sekerel BE; Siebenhaar F; Siiskonen H; Soria A; Staubach-Renz P; Stingeni L; Sussman G; Szegedi A; Thomsen SF; Vadasz Z; Vestergaard C; Wedi B; Zhao Z; Maurer M
Allergy; 2022 Mar; 77(3):734-766. PubMed ID: 34536239
[TBL] [Abstract][Full Text] [Related]
19. Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.
He L; Yi W; Huang X; Long H; Lu Q
Clin Rev Allergy Immunol; 2021 Dec; 61(3):424-448. PubMed ID: 34529248
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Network Meta-analysis.
Nochaiwong S; Chuamanochan M; Ruengorn C; Awiphan R; Tovanabutra N; Chiewchanvit S
JAMA Dermatol; 2021 Nov; 157(11):1316-1327. PubMed ID: 34431983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
